LIANA PORCHIE: Open Payments
NPI 1346811445 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$680 in 32 payments from 9 companies in 2025. Trend: 2023 $899 · 2024 $735 · 2025 $680
Food & beverage: $680
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $322 |
| Lilly USA, LLC | 4 | $85 |
| Ardelyx, Inc. | 3 | $72 |
| Janssen Biotech, Inc. | 2 | $45 |
| Madrigal Pharmaceuticals | 2 | $42 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $38 |
| Intercept Pharmaceuticals, Inc. | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Ipsen Biopharmaceuticals, Inc | 1 | $24 |
Products named: RINVOQ, OMVOH, IBSRELA, LINZESS, SKYRIZI, TREMFYA, REZDIFFRA, XIFAXAN.
Industry payments across VA — which companies pay providers there.
